Daniel Thurley is the general manager for Roche Pharmaceuticals in Hong Kong and Macau.
Reporting to the regional office for Roche in Asia, Dr Thurley has been responsible for all aspects of Research, Development and commercial operations since 2018. Previously, he was the general manager for Roche Pharmaceuticals in New Zealand; prior to this he was medical director in Australia, UK, Singapore and Switzerland in local, regional and global roles for over a decade.
Dr Thurley is a United Kingdom trained consultant physician (Cambridge University) who has alsopracticed clinically in several countries around the world, primarily in the field of Medical Oncology.
He is a member of the Royal College of Physicians (Edinburgh), and is a fellow of the Faculty of Pharmaceutical Medicine, and until 2019 was an examiner for the UK College. He is a member of the American Society of Clinical Oncology (ASCO), and in Hong Kong, a vice president of the Board of Directors of the Hong Kong Association of the Pharmaceutical Industry (HKAPI).